theory clinical_2_2
imports Main


begin

typedecl entity
typedecl event

consts
  SyntheticLethality :: "entity ⇒ bool"
  CoOccurrence :: "event ⇒ bool"
  GeneticEvents :: "event ⇒ bool"
  CellDeath :: "entity ⇒ bool"

(* Explanation 1: Synthetic lethality is when co-occurrence of multiple genetic events results in cell death *)
axiomatization where
  explanation_1: "∀x y z. SyntheticLethality x ⟷ CoOccurrence y ∧ GeneticEvents y ∧ CellDeath z"

consts
  PARPInhibitors :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  ReplicationDoubleStrandBreaks :: "entity ⇒ bool"
  Preventing :: "event ⇒ bool"
  SingleStrandBreakRepair :: "event ⇒ bool"
  RelyingOn :: "event ⇒ bool"
  DefectiveHomologousRecombinationRepair :: "event ⇒ bool"
  ErrorProneNonHomologousEndJoining :: "event ⇒ bool"
  Repair :: "event ⇒ bool"
  DNA :: "entity ⇒ bool"

(* Explanation 2: PARP inhibitors cause replication‐associated double strand breaks by preventing single strand break repair, relying on defective homologous recombination repair and error prone non-homologous end joining to repair DNA *)
axiomatization where
  explanation_2: "∃x y z e. PARPInhibitors x ∧ Cause e ∧ ReplicationDoubleStrandBreaks y ∧ Preventing e ∧ SingleStrandBreakRepair e ∧ RelyingOn e ∧ DefectiveHomologousRecombinationRepair e ∧ ErrorProneNonHomologousEndJoining e ∧ Repair e ∧ DNA z"


theorem hypothesis:
 assumes asm: "Patients x ∧ LossBRCA2 x"
  (* Hypothesis: Patients with loss of BRCA2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA *)
 shows "∃x y z e. Patients x ∧ LossBRCA2 x ∧ PARP1 y ∧ Inhibition e ∧ Benefit e ∧ Agent e x ∧ Reason e z ∧ SyntheticLethality z ∧ Cause z ∧ RelyOn z ∧ Mechanism z ∧ Repair z ∧ DamageDNA z"
  sledgehammer
  oops

end
